The COVID-19 pandemic highlighted the need for specialized care and prompted the division’s creation, according to a Nov. 1 release from the hospital. The new division will lead treatment of emerging infections like monkeypox, manage efforts in infection prevention and control, and transplant infectious diseases. The unit will also establish clinical guidelines for managing infections and their complications.
Dr. Ballan will be joined by Scott Ostdiek, MD; Julia Piwoz, MD; and Matthew Smith, MD.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
